ストックスクリーナーアプリを入手
5.465
4.79%
-0.275
アフターアワーズ：
5.47
0.005
+0.09%
前日終値:
$5.74
開ける：
$5.78
24時間の取引高:
50,701
Relative Volume:
1.04
時価総額：
$51.62M
収益：
$5.12M
当期純損益:
$-67.00M
株価収益率:
-3.7177
EPS:
-1.47
ネットキャッシュフロー:
$-38.94M
1週間 パフォーマンス:
-8.31%
1か月 パフォーマンス:
-24.31%
6か月 パフォーマンス:
-25.76%
1年 パフォーマンス:
-80.41%
1日の値動き範囲:
$5.40
$5.78
1週間の範囲:
$5.40
$6.36
52週間の値動き範囲:
$3.816
$29.70
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
名前
Verrica Pharmaceuticals Inc
セクター
電話
484-453-3300
住所
10 NORTH HIGH STREET, WEST CHESTER, PA
VRCA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
5.465 | 58.14M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-06 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-07-25 | アップグレード | Needham | Hold → Buy |
| 2023-03-22 | 開始されました | Jefferies | Buy |
| 2023-02-13 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-05-25 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-05-14 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-12-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-06-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-24 | 開始されました | Northland Capital | Outperform |
| 2020-03-24 | 開始されました | Needham | Buy |
| 2019-02-21 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Verrica Pharmaceuticals Inc (VRCA) 最新ニュース
Published on: 2025-08-21 06:55:08 - newsyoung.net
Bollinger Bands Expand on Verrica Pharmaceuticals Inc. — Volatility AheadMarket Weekly Review & Weekly Setup with High ROI Potential - thegnnews.com
Short Interest in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Declines By 32.3% - Defense World
Verrica Pharmaceuticals Inc.’s volatility index tracking explainedInsider Buying & Expert-Curated Trade Recommendations - Newser
Can Verrica Pharmaceuticals Inc. hit a new high this monthTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
Real time scanner hits for Verrica Pharmaceuticals Inc. explainedQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Detecting price anomalies in Verrica Pharmaceuticals Inc. with AIJuly 2025 Highlights & Low Risk Investment Opportunities - Newser
Verrica Pharmaceuticals Streamlines Operations to Enhance YCANTH Access - MSN
Verrica Pharmaceuticals Inc. stock trend outlook and recovery pathWeekly Stock Recap & Weekly High Conviction Trade Ideas - Newser
Is Verrica Pharmaceuticals Inc. showing signs of accumulationQuarterly Trade Review & Free Accurate Trade Setup Notifications - Newser
What earnings revisions data tells us about Verrica Pharmaceuticals Inc.July 2025 Closing Moves & Weekly Setup with ROI Potential - Newser
Verrica Pharmaceuticals Posts Strong Q2 Growth, Advances Basal Cell Carcinoma Program - MSN
Can Verrica Pharmaceuticals Inc. recover in the next quarter2025 Market Sentiment & Daily Market Momentum Tracking - Newser
Leading vs lagging indicators on Verrica Pharmaceuticals Inc. performance2025 Short Interest & Target Return Focused Stock Picks - Newser
Real time social sentiment graph for Verrica Pharmaceuticals Inc.July 2025 Decliners & Low Risk High Reward Ideas - Newser
Verrica Pharmaceuticals Inc. Ranks High in Smart Money TrackerWeekly Trading Summary & Free Safe Capital Growth Stock Tips - beatles.ru
Can machine learning forecast Verrica Pharmaceuticals Inc. recoveryQuarterly Trade Review & Growth Focused Entry Reports - Newser
Analyzing drawdowns of Verrica Pharmaceuticals Inc. with statistical tools - Newser
Sentiment analysis tools applied to Verrica Pharmaceuticals Inc.Market Volume Summary & Real-Time Volume Triggers - Newser
What does recent volatility data suggest for Verrica Pharmaceuticals Inc.Market Risk Analysis & Growth Focused Stock Reports - Newser
Verrica Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - Newser
Is Verrica Pharmaceuticals Inc. trending in predictive chart modelsTake Profit & Verified Swing Trading Watchlist - Newser
Does Verrica Pharmaceuticals Inc. have declining or rising EPSQuarterly Market Review & Scalable Portfolio Growth Ideas - sundaytimes.kr
Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attention2025 Historical Comparison & Reliable Volume Spike Alerts - Newser
Market reaction to Verrica Pharmaceuticals Inc.’s recent newsGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser
Sector ETF Data Correlates with Strength in Verrica Pharmaceuticals Inc.Trade Analysis Report & Growth Oriented Trading Recommendations - sundaytimes.kr
What makes Verrica Pharmaceuticals Inc. stock price move sharply2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
Historical volatility pattern of Verrica Pharmaceuticals Inc. visualized2025 Major Catalysts & Long Hold Capital Preservation Plans - Newser
Verrica Pharmaceuticals shares rise 2.28% after-hours following Q2 2025 earnings call. - AInvest
Verrica Posts Profit in Fiscal Q2 - AOL.com
Verrica Pharmaceuticals stock price target raised to $20 by TD Cowen - Investing.com Canada
Verrica Pharmaceuticals Reaches Nasdaq Compliance, Q2 Revenue at $12.7M - AInvest
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q2 2025 Earnings Call Transcript - Insider Monkey
Verrica Pharmaceuticals: Promising Sales Growth Amid Financial Stability Concerns - TipRanks
Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates - MSN
Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlig - GuruFocus
Verrica Pharmaceuticals Sees Revenue Surge in Q2 2025 - TipRanks
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewswire
Verrica Posts Profit in Fiscal Q2 - The Motley Fool
Verrica Pharmaceuticals' Q2 2025: Unpacking Contradictions in Sales Strategies, Seasonality, and Patient Access - AInvest
Verrica Pharmaceuticals (VRCA) Q2 2025 Earnings and Strategic Pipeline Catalysts: A Case for Re-Rating and Investor Re-Entry - AInvest
Earnings call transcript: Verrica Pharmaceuticals Q2 2025 beats EPS forecast By Investing.com - Investing.com Nigeria
Earnings call transcript: Verrica Pharmaceuticals Q2 2025 beats EPS forecast - Investing.com
Verrica Pharmaceuticals Regains Nasdaq Compliance - TipRanks
VERRICA PHARMACEUTICAL Earnings Results: $VRCA Reports Quarterly Earnings - Quiver Quantitative
Verrica Pharmaceuticals earnings beat by $0.11, revenue topped estimates - Investing.com Canada
Verrica Pharmaceuticals Inc (VRCA) 財務データ
収益
当期純利益
現金流量
EPS
Verrica Pharmaceuticals Inc (VRCA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hayes Christopher G. | CHIEF LEGAL OFFICER |
Aug 26 '24 |
Sale |
2.66 |
26,183 |
69,647 |
115,303 |
| Hayes Christopher G. | CHIEF LEGAL OFFICER |
Aug 27 '24 |
Sale |
2.46 |
9,530 |
23,444 |
105,773 |
| Goldenberg Gary | Chief Medical Officer |
Aug 26 '24 |
Sale |
2.66 |
9,888 |
26,302 |
97,862 |
| Goldenberg Gary | Chief Medical Officer |
Aug 27 '24 |
Sale |
2.46 |
3,601 |
8,858 |
94,261 |
| Bonaccorso Joe | CHIEF COMMERCIAL OFFICER |
Aug 26 '24 |
Sale |
2.66 |
24,709 |
65,726 |
82,107 |
| Bonaccorso Joe | CHIEF COMMERCIAL OFFICER |
Aug 27 '24 |
Sale |
2.46 |
8,993 |
22,123 |
73,114 |
| Kohler Terry | CHIEF FINANCIAL OFFICER |
Aug 26 '24 |
Sale |
2.66 |
21,820 |
58,041 |
52,596 |
| Kohler Terry | CHIEF FINANCIAL OFFICER |
Aug 27 '24 |
Sale |
2.46 |
7,899 |
19,432 |
44,697 |
| White Ted | PRESIDENT AND CEO |
Aug 26 '24 |
Sale |
2.66 |
24,979 |
66,444 |
224,988 |
| White Ted | PRESIDENT AND CEO |
Aug 27 '24 |
Sale |
2.46 |
9,021 |
22,192 |
215,967 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):